Chimerix

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Chimerix and other ETFs, options, and stocks.

About CMRX

Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox.

CEO

Michael T. Andriole

CEOMichael T. Andriole

Employees

Employees72

Headquarters

Durham, North Carolina

HeadquartersDurham, North Carolina

Founded

2000

Founded2000

Employees

Employees72

CMRX Key Statistics

Market cap

269.81M

Market cap269.81M

Price-Earnings ratio

-3.20

Price-Earnings ratio-3.20

Dividend yield

—

Dividend yield—

Average volume

23.06M

Average volume23.06M

High today

$3.19

High today$3.19

Low today

$2.76

Low today$2.76

Open price

$2.85

Open price$2.85

Volume

2.53M

Volume2.53M

52 Week high

$3.39

52 Week high$3.39

52 Week low

$0.75

52 Week low$0.75

Chimerix

Why Robinhood?

Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. Show more

CMRX Key Statistics

Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox.